The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease

2004 ◽  
Vol 287 (4) ◽  
pp. F775-F788 ◽  
Author(s):  
Mahmoud Loghman-Adham ◽  
Carlos E. Soto ◽  
Tadashi Inagami ◽  
Lisa Cassis

Hypertension is a common complication of autosomal dominant polycystic kidney disease (ADPKD), often present before the onset of renal failure. A role for the renin-angiotensin system (RAS) has been proposed, but studies of systemic RAS have failed to show a correlation between plasma renin activity and blood pressure in ADPKD. Ectopic renin expression by cyst epithelium was first reported in 1992 (Torres VE, Donovan KA, Sicli G, Holley KE, Thibodeau ST, Carretero OA, Inagami T, McAteer JA, and Johnson CM. Kidney Int 42: 364–373, 1992). It is not known, however, whether other RAS components are also expressed by cysts in ADPKD. We show that, in addition to renin, angiotensinogen (AGT) is produced by some cysts and dilated tubules. Angiotensin-converting enzyme, ANG II type 1 receptor, and ANG II peptide are also present within cysts and in many tubules; and some cyst fluids contain high ANG II concentrations. Additionally, cyst-derived cells in culture continue to express the components of the RAS at both the protein and mRNA levels. We further show that renin is expressed primarily in cysts of distal tubule origin and in cyst-derived cells with distal tubule characteristics, whereas AGT is expressed primarily in cysts of proximal tubule origin and in cyst-derived cells with proximal tubule characteristics. Renin production by cyst-derived cells appears to be regulated by extracellular Na+ concentration. Based on these observations, we propose a model of an autocrine/paracrine RAS in polycystic kidney disease, whereby overactivity of the intrarenal system results in sustained increases in intratubular ANG II concentrations.

2012 ◽  
Vol 302 (8) ◽  
pp. F917-F927 ◽  
Author(s):  
Carolina Cannillo Graffe ◽  
Jesper Nørgaard Bech ◽  
Thomas Guldager Lauridsen ◽  
Erling Bjerregaard Pedersen

Renal handling of sodium and water is abnormal in chronic kidney diseases. To study the function and regulation of the aquaporin-2 water channel (AQP2) and the epithelial sodium channel (ENaC) in autosomal dominant polycystic kidney disease (ADPKD), we measured urinary excretion of AQP2 (u-AQP2), the β-subunit of ENaC (u-ENaCβ), cAMP (u-cAMP), and prostaglandin E2 (u-PGE2); free water clearance (CH2O); fractional sodium excretion (FENa); and plasma vasopressin (p-AVP), renin (p-Renin), angiotensin II (p-ANG II), aldosterone (p-Aldo), and atrial and brain natriuretic peptide (p-ANP, p-BNP) in patients with ADPKD and healthy controls during 24-h urine collection and after hypertonic saline infusion during high sodium intake (HS; 300 mmol sodium/day) and low sodium intake (LS; 30 mmol sodium/day). No difference in u-AQP2, u-ENaCβ, u-cAMP, u-PGE2, CH2O, and vasoactive hormones was found between patients and controls at baseline, but during HS the patients had higher FENa. The saline caused higher increases in FENa in patients than controls during LS, but the changes in u-ENaCβ, p-Aldo, p-ANP, p-BNP, p-Renin, and p-ANG II were similar. Higher increases in u-AQP2 and p-AVP were seen in patients during both diets. In conclusion, u-AQP2 and u-ENaCβ were comparable in patients with ADPKD and controls at baseline. In ADPKD, the larger increase in u-AQP2 and p-AVP in response to saline could reflect an abnormal water absorption in the distal nephron. During LS, the larger increase in FENa in response to saline could reflect a defective renal sodium retaining capacity in ADPKD, unrelated to changes in u-ENaCβ.


Sign in / Sign up

Export Citation Format

Share Document